Posts by Sandra Ansanay-Alex
Cruise Giant MSC Set To Buy Hirslanden Clinics
The clinic group is soon to be acquired by the Geneva-based shipping giant. The restructuring is expected to be completed by the end of 2026.
Read MoreNew AI Hub for Brain Health at Campus Biotech
This new center is designed to accelerate the development of neuromodulation technologies for psychiatric and neurological disorders.
Read MoreGeneva to Host the 14th IAS Conference on HIV Science in 2027
On World AIDS Day 2025, the International AIDS Society (IAS) and Geneva University Hospitals (HUG) announced that Geneva has been selected to host the 14th IAS Conference on HIV Science, taking place from 11 to 15 July 2027. This major global gathering — expected to welcome more than 5,000 participants — comes at a critical…
Read MorePacrim Group Acquires Majority Stake in Medropharm AG
Valais-based Pacrim Group has taken a major strategic step in the Swiss life-science landscape by acquiring a controlling majority of Medropharm AG, a pioneer in pharmaceutical-grade cannabis. Announced on 21 October 2025, the transaction positions Pacrim — together with its subsidiary Alponics SA — as Switzerland’s only fully integrated medicinal cannabis enterprise, spanning the entire value chain from plant genetics to patient-ready products.
Read MoreGlobal Innovation Summit 2026
The Global Innovation Summit 2026 is taking place on 6 May 2026 in Basel and is the opportunity to kick off your innovation project with international partners, strengthen your business and explore suitable funding opportunities in over 40 countries. The Global Innovation Summit is a recurring gathering organised in the framework of Eureka the world’s largest network…
Read MoreTakeda Unveils New State-of-the-Art Biotech Facility in Neuchâtel
Japonese company Takeda has reached an important milestone in Western Switzerland with the inauguration of a new aseptic filling facility in Neuchâtel — a major investment that strengthens both regional innovation and global access to life-changing therapies. With more than CHF 200 Million invested, this is the largest expansion ever made at the site. Boosting…
Read MoreArtiria Medical Secures CE Mark for it SmartGUIDE™ 014, a Deflectable Guidewire
Artiria Medical, an EPFL spinoff and Swiss innovator in neurovascular technologies, announces that its SmartGUIDE™ 014 deflectable guidewire, a next-generation guidewire specifically developed for neurovascular interventions, has received CE Mark certification under the European Medical Device Regulation (EU MDR). The SmartGUIDE™ 014 is engineered to support physicians in navigating the intricate and delicate blood vessels…
Read MoreChallenge Qualité de Vie du Patient
The 10th anniversary of the Challenge Qualité de Vie du Patient Debiopharm Inartis is taking place on 8 December 2025 in Lausanne. Ten years ago, an ambitious initiative was launched: the Patient Quality of Life Challenge. A decade later, the progress made is clear. What began as a bold idea has grown into a catalyst…
Read MoreTrust Valley Day
Trust Valley Day is taking place on 2 December 2025 at International Conference Center Geneva.
Read MoreBracco, Limula and UNIFR Join Forces to Create Efficient Cancer Cell Therapies
Cell and gene therapies are promising, but remain extremely expensive. The pharmaceutical company Bracco Imaging, a leader in medical imaging, Limula, a company specialising in the automation of cell therapies, and Professor Nicola Vannini of the University of Fribourg are joining forces to make them more accessible. This public-private partnership is receiving CHF 688,000 in…
Read More